A new type of Ca(2+)-dependent, Mg(2+)-stimulated ATPase of rat liver plasma membrane.
Incubation of a glycoprotein fraction obtained from rat liver plasma membrane which has been previously well characterized using [gamma-32P]ATP results in the phosphorylation of a 230-kDa glycoprotein (pgp230). It is composed of a 120-kDa subunit (pgp120) and a 110-kDa subunit (pgp110) linked by interchain disulfide bonds. Peptide maps of pgp120 and pgp110 suggest extensive similarity in their polypeptide chains. Glycan analysis reveals between four and six hybrid-type oligosaccharide chains for both phosphoproteins. Immunoblotting using monoclonal antibodies and endoglycosidase digestion exclude an identity of pgp120 or pgp110 with the hepatocyte plasma membrane glycoproteins dipeptidylpeptidase IV or the taurocholate transport protein, which co-purify and co-migrate in SDS/PAGE. Protein phosphorylation is Ca(2+)-dependent (K0.5(Ca2+) = 0.35 microM, in the absence of Mg2+). In the presence of Mg2+, the glycoprotein undergoes rapid cycles of phosphorylation and dephosphorylation, resulting in ATPase activity. Analysis of phosphorylated amino acids identifies phosphothreonine as the major one. Photoaffinity labeling with 8-azido-[alpha-32P]ATP demonstrates the presence of one or more ATP binding site(s). Preincubation of pgp230 with various purine or pyrimidine nucleotides (ATP, UTP, TTP, ADP, GDP, AMP, CMP) or known P2-purinoceptor agonists or antagonists (adenosine 5'-[alpha,beta-methylene]triphosphate, 2-methyl-thio-adenosine 5'-triphosphate, suramin) inhibits its phosphorylation by [gamma-32P]ATP. The biological function of pgp230 is unknown at present. Several findings of the present study are compatible with the idea that pgp230 may be involved in a P2-purinoceptor function of the hepatocyte. Following this concept, a mechanism is discussed where a cytosolically exposed high-affinity Ca(2+)-binding site of pgp230 would allow for receptor feedback control, via phosphorylation and dephosphorylation, by sensing changes in cytosolic Ca2+ concentration.
Heilmann
C
C
Abteilung Gastroenterologie und Hepatologie, Medizinische Klinik, Albert-Ludwigs-Universität, Freiburg, Germany.
Spamer
C
C
Mössner
W
W
Dietz
C
C
Reutter
W
W
Kreisel
W
W
D000255:Adenosine Triphosphate / Q000031:analogs & derivatives / Q000378:metabolism; D000345:Affinity Labels; D000818:Animals; D000911:Antibodies, Monoclonal; D001386:Azides; D001665:Binding Sites; D017301:Ca(2+) Mg(2+)-ATPase / Q000032:analysis / Q000737:chemistry / Q000378:metabolism*; D002462:Cell Membrane / Q000201:enzymology; D002478:Cells, Cultured; D006026:Glycoside Hydrolases / Q000378:metabolism; D015151:Immunoblotting; D008099:Liver / Q000201:enzymology*; D008562:Membrane Glycoproteins / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism*; D008970:Molecular Weight; D009711:Nucleotides / Q000494:pharmacology; D010449:Peptide Mapping; D010766:Phosphorylation; D010769:Phosphothreonine / Q000378:metabolism; D051381:Rats
D000345:Affinity Labels; D000911:Antibodies, Monoclonal; D001386:Azides; D008562:Membrane Glycoproteins; D009711:Nucleotides; D010769:Phosphothreonine; C017040:8-azidoadenosine 5'-triphosphate; D000255:Adenosine Triphosphate; D006026:Glycoside Hydrolases; D017301:Ca(2+) Mg(2+)-ATPase